INOVIO PHARMACEUTICALS, INC. (INO) Operating margin 2016–2025
INOVIO PHARMACEUTICALS, INC. (INO) operating margin by fiscal year — reported operating income divided by reported revenue.
-132871.3%FY2025 · since FY2016: -215.5% → -132871.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -132871.3% | -81254.4 pp |
| FY2024 | -51616.9% | -34316.6 pp |
| FY2023 | -17300.3% | -14692.9 pp |
| FY2022 | -2607.4% | +14365.0 pp |
| FY2021 | -16972.3% | -15298.1 pp |
| FY2020 | -1674.2% | +1027.9 pp |
| FY2019 | -2702.1% | -2393.4 pp |
| FY2018 | -308.7% | -110.6 pp |
| FY2017 | -198.1% | +17.4 pp |
| FY2016 | -215.5% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice